NCT05757531View on ClinicalTrials.gov

A Study of Carbon-14-Labelled [14C] LY3437943 in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

7

Participants

Timeline

Start Date

March 17, 2023

Primary Completion Date

June 23, 2023

Study Completion Date

June 23, 2023

Conditions

Healthy

Interventions

DRUG

[¹⁴C]-LY3437943

Administered SC.

Trial Locations (1)

53704

Covance Clinical Research Unit, Madison

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY